Back to Journals » ImmunoTargets and Therapy » Volume 6

Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer

Total article views   HTML views PDF downloads Totals
10,461 Dovepress* 9,230+ 1,939 11,169
PubMed Central* 1,231 373 1,604
Totals 10,461 2,312 12,773
*Since 20 March 2017
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar